CORRESP Filing
RenovoRx, Inc.
Date: April 23, 2026 · CIK: 0001574094 · Accession: 0001493152-26-018717
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-295108
Letter
VIA EDGAR Division of Corporation Finance Office of Life Sciences Attention: Alan Campbell Re: RenovoRx, Inc. Registration Statement on Form S-3 Filed April 16, 2026 File No. 333-295108
Dear Mr. Campbell:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, RenovoRx, Inc. (the “Company”) hereby requests acceleration of effectiveness of the above referenced Registration Statement, so that it will become effective at 4:30 p.m., Eastern time, on Monday, April 27, 2026 (the “Effective Time”). The Company hereby grants to Lawrence A. Rosenbloom, Esq. of Ellenoff Grossman & Schole LLP the authority to communicate to the staff of the U.S. Securities and Exchange Commission one or more requests for any potential deferral of the Effective Time.
Very
truly yours,
/s/
Shaun R. Bagai
Show Raw Text
CORRESP
1
filename1.htm
RENOVORX,
INC.
2570
West El Camino Real, Suite 640
Mountain
View, CA 94040
April
23, 2026
VIA
EDGAR
U.S.
SECURITIES AND EXCHANGE COMMISSION
Division
of Corporation Finance
Office
of Life Sciences
100
F Street, N.E.
Washington,
DC 20549
Attention:
Alan Campbell
Re:
RenovoRx,
Inc.
Registration
Statement on Form S-3
Filed
April 16, 2026
File
No. 333-295108
Dear
Mr. Campbell:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended, RenovoRx, Inc. (the “Company”) hereby requests acceleration
of effectiveness of the above referenced Registration Statement, so that it will become effective at 4:30 p.m., Eastern time, on Monday,
April 27, 2026 (the “Effective Time”). The Company hereby grants to Lawrence A. Rosenbloom, Esq. of Ellenoff Grossman
& Schole LLP the authority to communicate to the staff of the U.S. Securities and Exchange Commission one or more requests for any
potential deferral of the Effective Time.
Very
truly yours,
/s/
Shaun R. Bagai
Shaun
R. Bagai
Chief
Executive Officer